Skip to main content
. 2008 Sep 7;2008:943614. doi: 10.1155/2008/943614

Figure 1.

Figure 1

Body weight gains in untreated and rosiglitazone (RGZ)-treated PPARγ f/f mice (a) and CD PPARγ knockout mice (b) (adapted from [28]).*, P < .05 versus vehicle at the corresponding time point.